Gene · 23765
Papers3,930
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,930
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An autonomous activation of interleukin-17 receptor signaling sustains inflammation and promotes disease progression. | Immunity | 2023 | 37473759 | PubTator, text mining | PubMed |
| Brodalumab for the treatment of plaque psoriasis in a real-life setting: a 3 years multicenter retrospective study-IL PSO (Italian landscape psoriasis). | Front Med (Lausanne) | 2023 | 37469659 | PubTator, text mining | PubMed |
| Effects of probiotics on non-alcoholic fatty liver disease: a review of human clinical trials. | Front Nutr | 2023 | 37457967 | PubTator, text mining | PubMed |
| The protective and pathogenic role of Th17 cell plasticity and function in the tumor microenvironment. | Front Immunol | 2023 | 37457739 | PubTator, text mining | PubMed |
| A novel immunogenic cell death signature for the prediction of prognosis and therapies in glioma. | PeerJ | 2023 | 37456890 | PubTator, text mining | PubMed |
| Modulation of IL-17 backbone dynamics reduces receptor affinity and reveals a new inhibitory mechanism. | Chem Sci | 2023 | 37449080 | PubTator, text mining | PubMed |
| Investigating the Crime Scene-Molecular Signatures in Inflammatory Bowel Disease. | Int J Mol Sci | 2023 | 37446397 | PubTator, text mining | PubMed |
| GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer. | Int J Mol Sci | 2023 | 37446056 | PubTator, text mining | PubMed |
| Regulatory Cues in Pulmonary Fibrosis-With Emphasis on the AIM2 Inflammasome. | Int J Mol Sci | 2023 | 37446052 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell Conditioned Medium Modulates Inflammation in Tenocytes: Complete Conditioned Medium Has Superior Therapeutic Efficacy than Its Extracellular Vesicle Fraction. | Int J Mol Sci | 2023 | 37446034 | PubTator, text mining | PubMed |
| Deciphering Common Traits of Breast and Ovarian Cancer Stem Cells and Possible Therapeutic Approaches. | Int J Mol Sci | 2023 | 37445860 | PubTator, text mining | PubMed |
| Sustaining the Activation of EGFR Signal by Inflammatory Cytokine IL17A Prompts Cell Proliferation and EGFR-TKI Resistance in Lung Cancer. | Cancers (Basel) | 2023 | 37444399 | PubTator, text mining | PubMed |
| Interaction of Interleukin-17A with a Th2 Response in a Mouse Model of Allergic Airway Inflammation. | Cells | 2023 | 37443808 | PubTator, text mining | PubMed |
| Small molecule inhibitors of RORγt for Th17 regulation in inflammatory and autoimmune diseases. | J Pharm Anal | 2023 | 37440911 | PubTator, text mining | PubMed |
| Differential expression profile of genes involved in the immune response associated to progression of chronic Chagas disease. | PLoS Negl Trop Dis | 2023 | 37440604 | PubTator, text mining | PubMed |
| Interleukin 17 in early invasive breast cancer. | Front Oncol | 2023 | 37427128 | PubTator, text mining | PubMed |
| Molecular modeling and rational design of disulfide-stapled self-inhibitory peptides to target IL-17A/IL-17RA interaction. | J Mol Recognit | 2023 | 37415317 | PubTator, text mining | PubMed |
| Novel Anti-Inflammatory Approaches to COPD. | Int J Chron Obstruct Pulmon Dis | 2023 | 37408603 | PubTator, text mining | PubMed |
| Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa Part I: Topical and Systemic Medical Therapies. | Dermatol Ther (Heidelb) | 2023 | 37402031 | PubTator, text mining | PubMed |
| Molecular basis of fluoride toxicities: Beyond benefits and implications in human disorders. | Genes Dis | 2023 | 37397522 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23765/papers?page=25